SKY-01 failure is not totally unexpected but likely to be seen as a negative read-through for anti-TIGIT space.

Scientists examine the effectiveness of an antibody targeting cell adhesion molecule 1 in alleviating pain-induced neuronal ...

研究结果表明，这种方法在多个方面都是有效的，其不仅能激活人类血液样本中正确类型的免疫细胞，还通过对动物模型进行研究发现，接受这种治疗的小鼠的生存期延长了，而且在更高的剂量下也能使得小鼠免于癌症影响，而且这种方法要比研究人员此前研究的癌症疗法更加安全。

Explore the challenges and advancements in anti-EGFR antibody treatment for metastatic colorectal cancer. Discover how ...

Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a ...

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for ...

A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...

Bright Biologics LLC reported the discovery and preclinical evaluation of BB-203, an anti-PD-L1/anti-VEGF bispecific antibody (Ab) being developed for the treatment of cancer.

Compugen (CGEN) announced that the United States Patent and Trademark Office has granted the company a new patent covering method of use for ...